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Urinary prostaglandins and seminal contamination. D. Benzoni, M.
Vincent, N. Gallo-Bona, and J. Sassard. Département de Physiologie
et Pharmacologic Clinique, Faculté de Pharmacie, Ct Laboratoire de
Physiologic A (Pr. J, F. Cier), Faculté de Médecine Grange Blanche,
Lyon, France. The measurement of urinary prostaglandins (PGs) is
usually considered a reliable index of the renal biosynthesis of PGs.
However, since the seminal fluid contains large amounts of PGs, it
appeared necessary to determine the effect of seminal contamination of
the urine on the elimination rate of urinary PGs. Urine was collected
from six healthy volunteers, free of any drugs, for 4 days after sexual
intercourse. On the five urinary samples successively obtained, PGE
and PGFa were measured by our previously described radio-
immunoassay. The urinary PGFa and more markedly PGE sharply
increased in the urine collected during the 24 hr following intercourse.
After that, they progressively returned to normal. The evolution of the
PGFaIPGE ratio (mean sEM) was established as: 0 to 12 hr: 0.25
0.07; 12 to 24 hr: 1.4 0.3; 24 to 48 hr: 3.0 0.3;48 to72 hr: 3.7 0.3;
72 to 96 hr: 3.5 0.2. The results were: (1) confirm that the seminal
fluid contains high amounts of PGE and (2) demonstrate that urinary
PGs measured in samples collected within the first 48 hr after sexual
intercourse do not reflect their renal biosynthesis accurately.
25-Hydroxyvitamin D, PTH, and nephrotic syndrome. Y. Berland, B.
Argemi, A. Robert, and M. Olmer. Service de Néphrologie, Ilôpital de
Ia Conception, et Lahoratoire de Recherches sur le Métabolisme
Phospho-Calcique, Hôpital de Ia Timone, Marseille, France. Calcium
metabolism in patients with nephrotic syndrome is impaired with
hypocalcemia and vitamin D deficiency. Our aim was the study of 33
nephrotic patients: Twenty-five had isolated nephrotic syndrome (NS).
and eight had associated chronic renal failure (NS + CRF). The
parathyroid function of the patients without chronic renal failure was
determined by EDTA infusion. There was no significant difference
either in serum albumin levels or in proteinuria between the two groups.
All the patients in both the NS and the NS + CRF groups had
hypocalcemia, 2.01 0.3 mmolelliter and 1.99 0.4 mmolelliter,
respectively, and lowered 25 OH vitamin D blood levels: 9.02 1.32 ngl
ml in the NS group and 8.23 2.55 nglml in the NS + CRF group.
Blood levels of parathyroid hormone (iPTH) were increased in patients
with NS + CRF, 33.75 5.96 eEq/ml but normal in the NS group,
12.94 1.69 Eqlml (normal range: 2 to 25 rEqlml). In patients with
normal renal function, EDTA infusion is valuable for detecting a
resistance to the calcemic action of iPTH. The data indicate that in
patients with NS and normal renal function a resistance to the calcemic
action of iPTH exists, probably relating to vitamin D deficiency.
AprotininTc99m: A low molecular weight protein for the study of renal
function. C. Bianchi, C. Donadio, G. Tramonti, P. Lorusso, L. Bellitto,
and F. Lung/ti. Cattedra di Nefrologia Medica, Clinica Medico 2,
Patologia Medico I, University of Pisa, Pisa, Italy. SORIN Biomedica,
Saluggia, Vercelli, Italy. The kidney plays an important role in the
turnover of low molecular weight proteins. We found that aprotinin (A),
a protease inhibiting low molecular weight polypeptide (6500 daltons),
could serve as a useful tool to study the renal handling of peptides and
to measure unilateral renal function. Pharmacokinetics of A labelled
with Tc99" was studied in 16 normal subjects and in 37 renal patients. In
normal subjects and in patients with moderate renal insufficiency,
plasma clearance (cl) of A was lower than GFR (mean ratio plasma cl Al
GFR = 0.68 0.22 sD). In four patients with renal failure plasma cI of A
exceeded GFR (mean ratio, 3.35). The apparent distribution volume of
A (percent of body weight) was 15.4 2.5 SD. Urinary excretion of
radioactivity in the first 2 hr after i.v. injection of A was negligible in all
patients (2.4 1.6 SD percent of the dose). Labelled A was accumulated
markedly and rapidly in the kidneys. In normal subjects, renal radioac-
tivity almost doubled between 2 mm and 2 hr after injection. Subse-
quently, renal activity remained remarkably stable until approximately
the ninth hour. Due to the rapid uptake and stable storage of A by the
kidney, highly satisfactory renal scans were obtained in all 79 patients,
including 23 patients with advanced renal failure. In normal subjects
and in those with symmetrical renal disease no difference between the
accumulation curve of the two kidneys was observed. On the contrary
in patients with unilateral renal disease the affected kidney exhibited a
renal curve flatter than that of the contralateral kidney. Conclusions:
Labelled A is promising for the study of renal handling of low molecular
weight proteins and for the measurement of unilateral renal function. It
is an excellent agent for renal imaging.
Prolonged plasmapheresis treatment of type 1 cryoglobulinemia with
membranoproliferative glomerulonephritis. P. L. Caraman, M. Kessler,
B. Hurault de Ligny, C. Huriet, F. Schooneman, and F. Streiff. Service
de Néphrologie, C.H.U. de Brabois, Vandoeuvre, ci Centre Regional
de Transfusion Sanguine, Rue Lionnois, Nancy, France. A 50-year-old
male had a 16-year history of peripheral vascular disease with the
diagnosis of type I cryoglobulinemia (gamma 2 kappa 2). Twelve years
later a nephrotic syndrome appeared; a renal biopsy was performed and
showed membranoproliferative glomerulonephritis. In June 1980 he
developed very severe necrotic lesions of the extremities and plasma-
pheresis was started. He received four to six exchanges every month
during two periods. (1) After four exchanges the necrotic lesions
improved dramatically and the patient remained well while plasmaphe-
resis was continued. Four months later B hepatitis occurred and the
treatment was stopped. Renal function deteriorated and hemodialysis
was performed. (2) One month later plasma exchanges were started
again; we observed an improvement of clinical status, serum creatinine
decreased; hemodialysis could be stopped. Plasma exchanges were
carried on during 6 months with very good stabilization. After the end
of plasmapheresis plasma creatinine increased and hemodialysis was
started again. The levels of cryoglobulinemia and the viscosity were
measured before and after each exchange and correlated with the
clinical course.
Tubular necrosis with chronic renal failure after combined chemo-
therapy including cisplatin. P. Deteix, T. Philip, S. Colon, M. Lay/he, C.
Sellem, Y. Rossarv, P. Zech, and J. Traeger. Clinique de nephrologie,
Hopital Edouard Herriot, ci Centre anti-cancéreux Leon Berard, Lyon,
France. A 19-year-old man was treated for a testicular embryonal
carcinoma with choriocarcinoma. Lymph nodes were involved. Che-
motherapy every 3 weeks included vinblastine, actinomycin, bleomy-
ci chlorambucil, and cisplatin (VAB III). Cisplatin was given in each
course at a single dose of 115 mglm2. Serum creatinine was normal at
the beginning of the sixth course. Three weeks later creatinine level was
920 zmoleslliter with normal diuresis. Pathologic study of a kidney
biopsy specimen (optic and electronic microscopy, immunofluores-
cence) showed no cellular proliferation or deposits in glomeruli, exten-
sive tubular lesions, mainly in proximal tubules, with severe mitochon-
drial alterations, and some interstitial inflammatory infiltrates. Ten
months after the beginning of renal failure, the level of renal function
still necessitates dialysis. Diuresis persists. Cancer is in complete
remission. It is hypothesized that inhibition of tubular epithelium
regeneration is by progressive renal cisplatin accumulation. Heavy
chemotherapy should be monitored by toxicity markers (creatinine
clearance, urinary tubular enzymes) and serum cisplatin level
determination.
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Relation between iron overload and gonadal function in hemodialysis
patients. J. M. Dueymes, P. Caron, J. P. Pourrat, C. Chougnet, J. P.
Moatti, J. P. Louvei, and J. J. Conte. Service de Nephrologie et
dHemodialyse; Service d'Endocrinologie; Laboratoire de Biochimie I;
Laboratoire de Biochimie II!, C.H.U. Toulouse-Purpan, France. Se-
rum ferritin is known to be a reliable index of body iron stores in
chronic hemodialysis patients. The possible association of iron over-
load with gonadal dysfunction, already known in hemochromatosis
patients, has been sought. Serum ferritin was measured in 51 patients
on chronic hemodialysis (39 men and 12 women). Values were signifi-
cantly above normal: 1256 1052 ng/ml (normal: 140 60) (P < I0—).
A correlation was found with dialysis duration (P < 0.05), iron
treatment and/or blood transfusion, serum iron level (P < 0.05), and
with mean erythrocyte volume (P < 0.01). Serum ferritin levels were
not different according to underlying renal disease. Thirty-nine male
patients, aged 50 14 years, were studied for gonadal function. Serum
prolactin, luteinizing hormone (LH), and follicle stimulating hormone
(FSH), before and after LHRH, were measured. We found: (1) an
increased value of LH-FSH, LH: 123 100 ng/ml (normal: 50 20) (P
< l0), FSH: 699 978 ng/ml (normal: 340 95) (P < 0.05), low LH-
FSH response after LHRH (at 25 mn: LH: 244 100, FSH: 754 1214);
(2) plasma prolactin significantly higher: 475 360 rU/ml (normal: 170
50) (P < 10). A good correlation is found between serum ferritin and
prolactin (r = 0.41, P < 0.02). In conclusion, we believe that iron
overload in the tissue of hemodialysis patients might participate in
hypothalamo-gonadal dysfunction.
Hypogonadism in male hemodialysis patients in relation to underlying
renal disease. J. M. Dueyrnes, P. Caron, J. P. Pourrat, J. P. Moatti,
J. P. Louvet, J. J. Conte. Service de Néphrologie et d'Hémodialyse;
Service d'Endocrinologie; Laboratoire de Biochimie III - C.H.U.
Toulouse-Purpan, France. The mechanisms by which male hemodialy-
sis patients are hypogonadic are still unclear. The relationship of this
dysfunction with the nature of the underlying renal disease has been
sought in 39 male patients, aged 50 14 years. dialyzed for 2.8 3
years, with urinary output 0.7 0.75 liter/24 hr. The cause of renal
failure was chronic glomerulonephritis (CGN) in 16 patients, chronic
interstitial nephritis (CIN) in 18 patients and polycystic disease (PD) in
three. Plasma testosterone levels, TeBG (Testosterone Binding Globu-
lin), estrogen, luteinizing hormone (LH), and follicle stimulating hor-
mone (FSH) were measured: (1) testosterone level was decreased
significantly: 247 73 mg/dl (normal: 500 50) (P < l0—), while TeBG
levels were normal: 0.85 0.54 ig/dl (normal: 0.93 0.31); (2)
estrogens were at the upper limit of normal: 2.93 0.75 ng/dl. (3) LH
and FSH levels were significantly higher than normal; LH: 123 100
ng/ml (normal: 50 20) (P < l0—), FSH: 699 978 ng/ml (normal: 340
95) (P < 0.05). These values were not different in 32 patients with or
without (16) gynecomastia and were not related to urinary output.
When studied according to underlying renal disease, a significant
difference was found for LH and FSH values: In CGN, LH was 181
129, in CIN 81 42(P <0.01), in PD 79 36. FSH was 1061 1421 in
CGN, 348 191 in CIN (P < 0.05), 263 89 in PD. In conclusion, the
increase of gonadotrophin levels is related primarily to hypogonadism
of peripheral origin. The difference in levels of LH and FSH according
to the nature of the renal disease suggests a prominent impairment of
cell function of the testis in CGN.
Severe hyperphosphatemia-induced nephrocalcinosis after chemothera-
py of acute lymphoblastic leukemia (ALL). J. L. Dutel, J. M. Boles, J.
Briere, M. Garre, J. Briere, CHU Morvan Brest, France. A rare
mechanism of acute renal failure (ARF) induced by anti-neoplastic
chemotherapy may necessitate systematic prophylaxis. An L2 FAB
type ALL in a 15-year-old boy was treated following the 12 LAL 80 St.
Louis protocol. Renal function was initially normal (creatininemia, 80
zmoles/liter) and uricemia was controlled with allopurinol and alkaline
diuresis. On the third day the patient developed ARF, hyperphosphate-
mia (P: 6.32 mmoles/liter), hypocalcemia (Ca: 1.2 mmoles/liter), Ca >< P
solubility product: 7.58 and aplasia (WBC count: 100/mm3). Hemody-
namic status was normal, blood cultures were negative, and the ratio of
urine uric acid to creatinine concentration on a urine specimen was
0.64. In spite of daily hemodialysis and symptomatic treatment, the
patient died 6 days later in a state of septic shock. Renal necropsy
performed 12 hr after death showed multiple crystalline deposits with
concentric structures in several tubular lumens. No lymphoblastic
infiltrates were found. Glomeruli and vessels were normal. Nephrocal-
cinosis was most probably induced by the extreme hyperphosphatemia
due to the acute tumor lysis syndrome following massive cytolysis
induced by chemotherapy. We suggest that the release of the phospho-
rus load concomitant with the initiation of chemotherapy in rapid cell
turnover malignant disease be prevented by oral phosphate chelators,
alkaline diuresis, and daily monitoring of phosphoremia.
Measurement of plasma oncotic pressure during the nephrotic syn-
drome. A. Feuillu, D. Chevet, B. Wehbe, P. Ic Pogamp, and N. Afiouni.
Unite de NCphrologie, Laboratoire de Reanimation, CHU Rennes,
France. This study was undertaken to compare plasma oncotic pressure
(POP) with the levels of albuminemia in patients with the nephrotic
syndrome (NS). The 54 patients studied consisted of 33 men and 21
women aged from 7 to 83 years (average: 45.6 years). Renal biopsy
specimen showed membranoproliferative GN (9), membranous GN (7),
focal glomerulosclerosis (10), minimal changes (7), lupus (1). diabetes
(1), Henoch-Schönlein purpura (2), other (8), and unclassified (9). When
the study was carried out, 28 patients had normal renal function; the
remaining had corrected 1.73 m2 body surface creatinine clearances
ranging from 60 to 6 mI/mm (average, 29.2 mI/mm). The treatments
prescribed were salt-free diet, diuretics and/or antihypertensive drugs,
aluminum hydrochloride and/or vitamin D3. Identical measurements
were repeated in eight patients after the proteinuria had disappeared
completely. Plasma albumin was measured by two different methods:
(I) the first using standard electrophoresis (ELPHO) to measure total
serum proteins (Biuret) and serving as criteria for inclusion in the study
if serum albumin was g/liter. (2) Bromocresol green (GREEN) was
used for the second method with the normal values determined using a
control population of 114 blood bank donors. Plasma albumin I SD =
49 I g/liter. The oncotic pressure was measured by a COP oncometer.
This technique necessitates a constant infusion of 200 /Ll in a measure-
ment chamber. The results are obtained within 2 mm. The values found
in the control group were 29 1.74 mm Hg. Student's t test was used
for statistical analysis. The decrease in serum albumin was in accord
and significant for all three methods versus their respective controls.
There was no significant difference between the serum albumin levels
(ELPHO vs. GREEN); the POP had a similar correlation coefficient
0.82 with these values. Renal failure did not influence the correlations.
Finally, return to normal values was observed in the eight patients in
whom proteinuria disappeared. Thus, oncotic pressure appears to be a
useful routine clinical measurement. These preliminary results confirm
its reproductiveness. Our data also show its reliability when compared
with the other standard methods in the case of NS. The measurement of
POP may well be superior to traditional determinations because it
involves a more pathophysiological parameter, it gives rapid results,
and is less expensive.
Acute renal failure associated with hypokalemic rhabdomyolysis. J. L.
Gail/ard, G. Fournier, G. Monchamps, and N. K. Man. Centre Hospi-
ta/icr de Chartres et DCpartement de Nephrologie de l'Hôpital Necker,
Paris, France. A 59-year-old white male was referred to the renal unit
for: (1) neuro-muscular disorders with drowsiness, motor function
impairment, absent tendon reflexes without either sensory disorder or
muscle mass volume alterations; (2) oliguria with dark brown urine.
Definite hypokalemia (1.3 mmoles/liter), hypocalcemia (1.5 mmoles/
liter), and hypochloremic (79 mmoles/Iiter) alkalosis (carbon dioxide
content 30 mmoles/liter) was associated with severe renal failure.
Plasma urea was 27.8 mmoles/liter and plasma creatinine 743 timoles/
liter. The water and electrolyte alterations resulted from an acute
gastroenteritis of staphylococcal origin with severe diarrhea and vomit-
ing during 4 days prior to the admission. The diagnosis of rhabdomyoly-
sis was based on myoglobinuria and strikingly high serum transamin-
ases (SGOT 428 IU and SGPT 145 IU), phosphocreatine kinase (over
25,000 IU), and lactic acid dehydrogenase (2,400 IU). After correction
of hypokalemia, hydratation and furosemide administration, the course
of renal failure was favorable without dialysis. Within 12 days, muscle
enzymes and renal function returned toward normal. Neurological
disorders diminished progressively. One month after the acute episode,
plasma urea was 7.2 mmoles/liter and plasma creatinine 100 rmmoles/
liter. In this case, rhabdomyolysis with myoglobinuria probably result-
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ed from gastroenteritis-induced potassium depletion since no other
causal factor such as trauma, myopathy, strenuous exertion, extreme
hyperthermia, viral illness, or drug or alcoholic intoxication was
present. This patient report illustrates the high diagnostic value of
phosphocreatinine kinase determination in the presence of any hypoka-
lemic acute renal failure.
Value for prognosis of coagulation tests in acute renal failure (ARF). F.
Jahjah, J. Sampol, A. Robert, and M. Oliner with technkal assistance
of A. Gil/el. Service de Nephro/ogie, Lahoratoire d'Héinato/ogie,
Hôpital de Ia Conception, Marseille, France. Coagulation tests were
done on a population of 35 patients with ARF. On admission day (D0)
and again for 15 patients on the seventh day (D,) we explored: platelet
count, fibrinogen, kaolin cephalin clotting time, prothrombin, alpha-2-
antiplasmin (a2 AP), alpha-2-macroglobulin (a2 macro G), alpha-I-
antitrypsin (a1 AT), C1 inhibitor (CI I), antithrombin III (AT111),
plasminogen (PG), factor VIII clotting activity (VIlI), factor VIII
related antigen (VIIIAg). ARF causes were functional (2), sepsis (5),
toxic nephropathy (7), postoperative (7), obstructive injury (10), cirrho-
sis (1) and unknown in three patients. Results included: On D0, platelet
counts were normal except in four patients (below 100,000/mm'). a, AP
and AT111 decreased; on the contrary, a2 macro G, a1 AT and especially
VIIIAg increased while C1 I and VIII. were within normal limits. Two
groups of patients were compared according to evolution at D,: group
A, eight survivors, and group B, seven nonsurvivors. Mean age was 61
6 and 66 4.5 years, respectively. PG and PG/VIIIAg ratios were
significantly lowered in group B (P < 0.001) as was AT, (P < 0.05). In
the latter group, PG remained lowered (P < 0.05) and VIIIAg at a very
high level whereas in group A it was normalized; again the difference is
quite significant (P < 0.001); PG/VIlla ratio remained lowered (P <
0.005) while VIIIA5/VIIIC ratio had increased significantly (P < 0.01).
Conclusion. In ARF, a plasminogen decrease and particularly a persist-
ing high V1IIAg level appear to indicate poor prognosis.
Accelerated glomerular damage in experimental nephrosis treated with
indomethacin (I). C. K/einknecht, D. Laouari, M. C. Gab/er, M.
Lacoste, and F. Gros. INSERM U. 192, HOpital des Enfants-Ma/ades,
Paris, France. A previous clinical trial suggested that I had a deleteri-
ous effect in children with chronic nephrosis. An experiment was
designed to study the long-term effects of tin rats with a heavy chronic
proteinuria induced by puromycine of aminonucleoside (PAN) injec-
tions. Three groups of 15 rats were compared. Two (A, B) received
PAN and were gavaged daily: group A with 1(2 mg/kg/d), group B with
glucose. C rats received I but no PAN. A and B rats developed heavy
proteinuria which was unaffected by 1(247 10 vs. 237 24 mg/d/lOO g
in A and B rats). In each group, four rats were killed after I month,
three after 2 months, three after 3 months, and five after 4 months.
Serum creatinine remained normal in A and B rats killed at 1 and 2
months, and in all C rats; it was elevated in seven of eight A rats and in
the two of eight B rats killed after 3 and 4 months (P < 0.02, x2 test).
The values were significantly higher mA rats (P <0.01, Mann-Whitney
test). Histology revealed no lesion in C rats. Both A and B rats had
severe tubular lesions on the kidneys taken at 1 month. Glomerular
damage with progressive hyalinosis and/or sclerosis developed later in
A and B rats, but more rapidly in A rats: of the rats killed after 2 and 3
months, six of six A rats and one of six B rats had at least 20% of their
glomeruli affected (P < 0.01). Of the kidneys taken after 3 and 4
months, seven of eight A rats and three of eight B rats had more than
50% glomeruli affected (P < 0.05). In conclusion, (1) no renal lesion was
ascribable to I alone; (2) the early tubular lesions resulted from the
direct tubular toxicity of PAN; (3) the lesions had the same pattern in
both PAN groups but their development was accelerated by I therapy.
The mechanism for this deleterious effect remains unclear.
B hepatitis associated mesangiocapillary glomerulonephritis (MCGN):
Positive indirect immunofluorescence for HBs in glomeruli. M. Lavi/le,
P. Deteix, S. Colon, C. Cheva/lier, P. Y. Zech, andJ. Traeger, Hop/ta!
F. Herr/of, Lyon, France. Circulating HBs is more frequent in patients
with nephropathies than in control patients. Frequence is particularly
high in glomerulopathies (9 to 35%) and especially in membranous
(45%) and mesangiocapillary (18%) glomerulonephritis. Direct involve-
ment of immune complex HBs-antiHBs in pathogenesis is related in
part to the presence of HBs Ag in glomeruli, which has been shown in a
few patients. We present a patient with controlled haiaul1 leukemia
and nephrotic syndrome. HBs and HBc were presOnti itt -the blood
(RIA). C1q binding test was positive. Complement was1aivated by the
classic pathway. Kidney biopsy specimen showed MUON (type I).
There was diffuse endocapillary proliferation, an increase in mesangial
matrix, a double basal lamina aspect, and small subcndothelial deposits.
Fluorescence microscopy showed subendothelial deposits with 1gM,
C1q, C4, C, staining. No posilivity was detected for IgA or IgO. Indirect
immunofluorescent test for HBs (rabbit antihuman and goat antirabbit
antiserum) was strongly positive in the subendothelial space. Controls
were negative. This is a new case of B virus associated MCGN, with
strong evidence of HBs antigen involvement in the pathogenesis of
kidney lesions, as suggested by the presence of HBs antigen in
glomeruli.
Renal argyria during nephrotic syndrome. C. Leroux-Robert, J.
Benevent, D. Benevent, M. J. Leboutet, M. Rince, P. Ga//c, and G.
Catanzano. C.H. U. Dupuytren Limoges, France. A 72-year-old woman
underwent renal biopsy for a nephrotic syndrome without arterial
hypertension, renal failure, or hematuria. Global glomerular sclerosis
was found in 50% of glomeruli. The others (15) had no hypercellularity
or focal and segmental sclerosing lesions. Dark granular deposits were
seen along the glomerular basement membrane. Such deposits were
also seen in tubular cells and the interstitium. Neither IgA, lgG, 1gM,
C1q, C3, or fibrinogen deposits were found by immunofluorescent
studies. Fine electron dense deposits (250 to 340 nm) were scattered
through the lamina densa. Juxtaposition of the foot processes of the
visceral epithelial cells was not noted. These deposits were studied by
electronprobe microanalysis, and they appeared to be constituted of
silver. This patient had no clinical sign of argyria, but similar deposits
were found in the skin and the hair. The origin of this intoxication
remains unknown. It is known by necropsy studies that in argyria silver
deposits are frequent in the kidney, whereas laboratory tests rarely
show renal abnormalities. In fact, in this patient, one may wonder
whether there is a link between the silver deposit and the nephrotic
syndrome or if it is a casual association.
Anaphylactoid purpura nephritis and transplantation. M. Levy, R.
Ami Moussa, R. Habib, M. F. Gagnadoux, and M. Broyer. HsISERM
U. 192, Service de Néphrologie Pedialrique, Hôpilal Necker Enfants-
Malades, Paris, France. Eleven of 166 children undergoing renal
transplantation during the period 1973 to 1980 originally had anaphylac-
toid purpura with crescentic glomerulonephritis. Duration of hemodial-
ysis varied from 3 to 38 months. Transplantation was performed 21 to 99
months after the clinical onset of anaphylactoid purpura. One patient
had had recurrences during the first year of hemodialysis prior to
transplantation, but no patient had a recurrence after transplantation.
One graft was lost due to irreversible acute rejection during the second
month and the patient received a second graft. Late results I to 8 years
after transplantation were: chronic rejection after 2.5 years, following
discontinuation of immunosuppressive drugs in one patient, creatinine-
mia> 130 zmoles/1iter in five patients and creatininemia < 130 zmoles/
liter in five patients. A biopsy of the transplanted kidney was performed
in eight patients. IgA mesangial deposits were present in six biopsy
specimens 1 to 3 years after transplantation. However, in one patient
deposits were demonstrated in a second biopsy at 3 years; they were
not present at Smooths. Of these five patients, only one had proteinuria
and hematuria whereas the others had no clinical evidence of glomeru-
lar disease. In two patients, deposits were not present in the biopsies
performed at 10 months and 3 years. In conclusion, although recurrence
of IgA mesangial deposits is frequent, results of transplantation per-
formed deliberately at least 1 year after the last recurrence of anaphy-
lactoid purpura appear to be good.
Anaphylactoid reactions during hemodialysis—Respunsibility of the
dialysis membrane (Cuprophan). F. Maurice, M. Kessler, D. A. Mon-
eret-Vautrin, B. Hurault de Ligny, P. L. Caraman, and C. Huriet,
Centre Hospitalier Regional, Nancy, France. Iterative hemodialysis
only rarely causes anaphylactoid reactions. In some cases it has been
possible to incriminate the sterilization agent (ethylene oxide, formalde-
hyde), one component of the dialysate (acetate) and in a few cases the
membrane. The observation of one patient suffering from chronic renal
failure who has been undergoing iterative hemodialysis treatment for
six years and in whom anaphylactoid reactions were noticed at the
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beginningfsth dialysis session carried out with a cuprophan mem-
brane is ruted. Three different types of dialysis membranes were
used: cuprophan, polyacrylonitrile, and cellulose acetate, and two
means of sterilization, ethylene oxide and gamma rays. The disorders
observed do not seem to be related to the usually described phenomena
occurring during hemodialysis. The clinical signs linked to major
hypereosinophilia (13000/mm3), hyperbasophilia (140/mm3), and an
increase in total IgE (> 1000 U/mI) disappear when the cuprophan
membrane is replaced with a cellulose acetate membrane. One year
later hypereosinophilia has disappeared, hyperbasophilia has subsided,
and total IgE level remains high. It is concluded that IgE-dependent
anaphylaxis might be due to one of the components of the cuprophan
membrane.
Treatment of renal amyloidosis with dimethyl sulfoxide (DMSO). F.
Mignon, J. F. Girard, J. Godin, J. Laederich, F. Chatelet, and M.
Beaufils. Services de Néphrologie, Hôpital Tenon et Hôpital Broussais,
Paris, HOpital de Bois Guillaume, Rouen, et Hôpital Intercommunal,
Montreuil, France. DMSO can block the precipitation of Bence-Jones
proteins by heat, can dissolve amytoid (A) fibrils in vitro and can
diminish the extent of amyloidosis in casein-treated mice, with coinci-
dent appearance of A-like material in the urine. Very few patients with
renal amyloidosis treated for long periods with DMSO have been
reported. In four departments of nephrology in France, only five
patients have been treated for 3 months or more. Many patients
discontinued treatment because of the garlic-like smell that dimethylsul-
fide produces on the breath.
Sex/Age
Amyloid
pattern Etiology
Cr DMSO
jimole/liter dose/day
Duration of
treatment
9 63 yrs A A Rehum Arth. (PR) 129 270 mg/kg > 1 year
9 58 yrs A A PR 167 6 months
9 43 yrsa A A FMF 200 220 mg/kg 9 months
d 65 yrs A L Unknown 70 300 mg/kg 3 m. died
d 47 yrs A L Unknown 100 80 mg/kg 3 m. died
a No amyloid-like material was found in the urine before and during
the treatment.
The anti-inflammatory action of DMSO has been confirmed (patients
nos. 1 and 2) and no side-effects were observed. Renal function was
unchanged during treatment, but the results are difficult to evaluate
without histological examination. Perhaps in the future, pharmacologi-
cal studies of drugs with the same antiamyloid properties as DMSO but
which are eliminated by different metabolic pathways might make
available a drug that patients find socially acceptable.
Reno-vascular complications of left atrial myxoma: Report of two
patients. F. Mignon, A. Meyrier, R. Cuvelier, L. Morel-Maroger, andf.
Dewilde. Service de Nephrologie, Hôpital Tenon, Paris, France. The
diagnosis is often difficult and delayed in left atrial myxoma (LAM),
which often mimics mitral valvulopathy with visceral embolism, or
even systemic arterial disease. Renal manifestations are rare. Two
patients with LAM are reported, including one with chronic renal
failure which led the patient to maintenance hemodialysis. Patient I:
This 43-year old female was investigated by angiography for several
cerebral ischemic episodes, lower limb arterial obstruction, and fever.
Arteriography disclosed multiple aneurisms of cerebral, hepatic, and
renal arteries. The nephrograms showed several cortical perfusion
defects. She was normotensive and had normal urinalysis and renal
function. A diagnosis of polyarteritis nodosa was considered, but the
renal biopsy specimen only showed zones of infarction without angeitis.
Cardiac angiography discovered a LAM which was operated on suc-
cessfully. Patient 2: This woman had been followed-up from 34 to 42
years of age for arterial embolism and an inflammatory syndrome. A
diagnosis of mitral valve stenosis was made without being substantiated
objectively. At age 37, obstructive material was removed from a
femoral artery. Pathological analysis was not performed. Unexplained
acute renal insufficiency occurred after the operation, with complete
return of renal function to normal within 3 weeks. Three years later she
was investigated in our unit for chronic renal failure (creatinine = 400
moles/Iiter). She was normotensive. Proteinuria was less than I g/24 hr
and the urinary sediment was inactive. The kidneys were shrunken and
their outer aspect was notched. Two years later cardiac echography
discovered a LAM which was surgically removed. Renal failure pro-
gressed relentlessly and led to maintenance hemodialysis within 6
months. These two patient histories illustrate the difficulties of diagno-
sis in left atrial myxoma with renal involvement. The pathophysiology
of renal failure is discussed.
Triamterene.induced nephrolithiasis. R. J. Reveillaud, M. Daudon,
M. F. Protat, Laboratoire Cristal, C. H. Saint-Cloud, Saint-Cloud,
France. Various studies have demonstrated a relationship between
nephrolithiasis and the ingestion of certain drugs. We are particularly
interested in the effects of triamterene. Five published patient studies of
both sexes between 43 and 60 years of age have proven that regular
consumption of normal doses of triamterene has a direct effect upon the
formation of renal stones; two patients were studied by our group. The
stones analyzed by infra-red spectrophotometry during the above
observations contained from 20 to 100% of triarnterene and its metabo-
lite, hydroxytriamterene, following a daily consumption of 150 to 350
mg during a period of 6 to 38 months, It has been confirmed that
triamterene and its metabolite, hydroxytriamterene, are very poorly
soluble and supersaturate the urine for a brief period following the
ingestion of the drug. Triamterene might also intervene in the initial
phenomena of nucleation. Therefore, it is recommended that triamter-
ene be used with caution in those patients presenting a history of
nephrolithiasis. The existence of drug-induced nephrolithiasis rein-
forces the importance of the technique of renal stone analysis and the
necessity of systematic study of all renal stones found. This will allow
us to develop the study of the correlations among the different episodes
of renal stone disease, the nature of the treatment undertaken, and the
systematic analysis, layer by layer, of the stone.
Nephrotic syndrome (NS) in secondary syphilis associated with a
concurrent positivation of HBs antigen. F. Schillinger, R. Montagnac,
C. Schiffmacher, P. Birembaut, and C. Hopfner. Nephrology-Hemodi-
alysis Department and Anatomy-Pathology Department, CHG of
Troyes; Pol Bouin Laboratory, CHU of Reims, France. The authors
report a 38-year-old patient with pure NS in full evolution of a
secondary syphilis. The subject had been infected two and one-half
months previously by homosexual intercourse, which also caused
positivation of HBs and HBe antigens, without associated hepatitis.
There was IgG-lgM cryoglobulinemia; the level of IgG, IgA, and 1gM
immunoglobulins was high and the level of C3 and C4 complement
components normal. No systemic disease was found. Light, immuno-
fluorescence (IF) and electron microscopic study indicated grade-I
membranous glomerulonephritis, with syphilitic etiology confirmed by
indirect IF and by the quick disappearance of proteinuria accompanied
by cure of NS after penicillin therapy. It took nearly one century to
confirm that syphilis might induce an "albuminous nephritis," as Rayer
suspected as far back as 1840. The treponemic specificity of glomerular
deposits, which are presumably due to circulating immune complexes,
could be demonstrated by renal histology, and particularly by IF, only
recently. Nephropathies, uncommon in this disease, occur as isolated
proteinuria, NS or, exceptionally, hematuric glomerulonephritis. This
finding calls for the following comments: (1) There are frequently
extramembranous and rarely subendothelial deposits in the nephrop-
athy of syphilis, now classified among immune complex diseases; (2)
the presence of the treponemic antigen and of the anti-treponemic
antibody in the kidney can be demonstrated respectively by indirect IF
and by elution; (3) the NS always develops favorably, either spontane-
ously or with penicillin therapy; (4) the incidence of the association
syphilis-HBs antigenemia in the homosexual is now well established,
the one requiring the search for the other.
Microangiopathic hemolytic anemia (MAHA) and renal failure after
blood transfusion in two patients treated with 5 Iluorouracil and mitomy-
cm c. P. Simon, M. P. Ramée, K. S. Ang, and J. Vignoux. Service de
Néphrologie CH Ia Beauchée, Saint-Brieuc, ci Service d'Anatomie
Pathologique CHU Pontchaillou Rennes, France. Two women, 48 and
58 years old, with cardia adenocarcinoma and ileum carcinoid tumor
were treated with Mitomycin C and fluorouracil after surgical resection.
Each patient had received drugs for 6 months when renal impairment
appeared. In patient I, thrombocytopenia and anemia were treated with
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repeated fresh blood transfusions and renal failure was exacerbated.
She died promptly and at necropsy there was no tumour recurrence.
Kidney histology revealed microangiopathic (MAT) changes with depo-
sition of fibrin in the small arteriole. Patient 2 received blood transfu-
sions and renal failure appeared subsequently. Renal biopsy specimen
showed MAT changes. In both patients glomerular lesions with mesan-
giolysis were prominent. In patient 2, MAHA improved and renal
failure stabilized after exchange plasmapheresis. In conclusion, treat-
ment with this drug combination is potentially dangerous and routine
monitoring of renal function is recommended, especially after blood cell
transfusion.
Lobular membranoproliferative glomerulonephritis associated with
chronic lymphocytic leukemia: Report of one patient with remission of the
neoplastic process and the nephrotic syndrome after chiorambucil predni-
sone therapy. G. Touchard, D. Gouet, R. Marechaud, 0. Pourrat, Y.
Sudre, J. Payen, and D. Patte, C.H.U. Jean Bernard Poitiers, France.
A 53-year-old man was admitted for evaluation of edema and hyperlym-
phocytosis. Nephrotic syndrome (NS) and chronic lymphocytic leuke-
mia (CLL) were diagnosed. Serum creatinine was 100 moles/liter and
creatinine clearance 110 mI/mm. Examination of peripheral blood
lymphocytes showed a B-cell monoclone secreting 1gM lambda surface
immunoglobulin. lgG lambda cryoglobulin and immune complexes
(PEG-C4) were found in the serum. CH5O was lowered with activation
of the classical pathway. Percutaneous renal biopsy specimen disclosed
interstitial lymphocytic leukemic infiltration and lobular membranopro-
liferative glomerulonephritis with predominant subendothelial deposits
of IgG, C3, Clq, C4, and fibrinogen. The fixation observed with the
anti-kappa and anti-lambda serum was the same as the fixation of the
anti-gamma serum. No deposits were found on the tubular basement
membranes. Electron microscopy showed voluminous subendothelial,
finely granular dense deposits, few subepithelial deposits, and fibrin
deposits with a fibrillar pattern. Neither organized deposits suggestive
of cryoglobulin nor amyloid were found. Chlorambucil-prednisone
therapy was started. Six months later the lymphocytosis and NS had
disappeared completely. NS has been reported in association with
CLL, but we have found only 10 patients with this association without
amyloidosis and renal vein thrombosis.
